These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29199997)

  • 1. Thrombolysis for Acute Ischemic Stroke After Protamine Reversal of Heparin.
    Danoun O; Sachar P; Rajamani K
    Am J Ther; 2018; 25(5):e552-e554. PubMed ID: 29199997
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteplase for Acute Ischemic Stroke after Heparin Reversal with Protamine: A Case Report and Review.
    Fontaine GV; Smith SM
    Pharmacotherapy; 2017 Oct; 37(10):e103-e106. PubMed ID: 28741720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis Following Heparin Reversal With Protamine Sulfate in Acute Ischemic Stroke: Case Series and Literature Review.
    Ranasinghe T; Mays T; Quedado J; Adcock A
    J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104283. PubMed ID: 31324409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis After Protamine Reversal of Heparin for Acute Ischemic Stroke After Cardiac Catheterization: Case Report and Literature Review.
    Warner DS; Schwartz BG; Babygirija R; Rovin RA; Kassam AB; Biddick L; Sajjad R; Chohan A; Panichpisal K
    Neurologist; 2018 Nov; 23(6):194-196. PubMed ID: 30379743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Danger of treatment protocols.
    Cucchiara B; Messé S; Kasner SE
    Stroke; 2003 May; 34(5):e19. PubMed ID: 12690208
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute ischemic stroke after cardiac catheterization: the protamine low-dose recombinant tissue plasminogen activator pathway.
    Guevara C; Quijada A; Rosas C; Bulatova K; Lara H; Nieto E; Morales M
    Blood Coagul Fibrinolysis; 2017 Apr; 28(3):261-263. PubMed ID: 27214037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic treatment of acute cerebral infarction.
    Burger KM; Horowitz DR
    CNS Spectr; 2005 Jul; 10(7):539-49. PubMed ID: 16155511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal multiple systemic emboli after intravenous thrombolysis for cardioembolic stroke.
    Tanaka K; Ohara T; Ishigami A; Ikeda Y; Matsushige T; Satow T; Ishibashi-Ueda H; Iihara K; Toyoda K
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):395-7. PubMed ID: 23545321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor reversal of low molecular weight heparin by protamine.
    Makris M; Hough RE; Kitchen S
    Br J Haematol; 2000 Mar; 108(4):884-5. PubMed ID: 10858037
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heparin or aspirin in the treatment of acute cerebral infarction?].
    Zuber M
    Rev Prat; 2001 Dec; 51(19):2057-9. PubMed ID: 11842722
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator.
    Leiva-Salinas C; Patrie JT; Xin W; Michel P; Jovin T; Wintermark M
    Stroke; 2016 Feb; 47(2):397-403. PubMed ID: 26696647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of protamine in the reversal of heparin in transcatheter aortic valve replacement.
    Lee PY; Viswanathan R; Chaudhry T; Hossain A; Lee T; Sharma A; Allencherril J
    J Cardiol; 2024 Aug; 84(2):143-145. PubMed ID: 38701946
    [No Abstract]   [Full Text] [Related]  

  • 13. [Delayed Diagnosis of Aortic Dissection Following Thrombolytic Therapy in a Patient with Acute Ischemic Stroke;Report of a Case].
    Miyamoto Y; Masuda Z; Kotani Y; Tarui S; Kuroko Y; Fujii Y; Ozawa S; Sano S
    Kyobu Geka; 2016 Nov; 69(12):1037-1040. PubMed ID: 27821831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
    Chest; 2004 Sep; 126(3 Suppl):483S-512S. PubMed ID: 15383482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATTEMPTS: a heparin/protamine-based prodrug approach for delivery of thrombolytic drugs.
    Liang JF; Park YJ; Song H; Li YT; Yang VC
    J Control Release; 2001 May; 72(1-3):145-56. PubMed ID: 11389993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early embolic events complicating intravenous thrombolysis for acute ischemic stroke.
    Chou PS; Lin CH; Chao HL; Chao AC
    Am J Emerg Med; 2012 Nov; 30(9):2079.e3-5. PubMed ID: 22205004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
    Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravenous tissue plasminogen activator in the treatment of acute ischemic stroke: feasibility, safety, and efficiency in the 2 first years of the clinical practice].
    Feuerhake W; Chamorro H; Araya F
    Rev Med Chil; 1999 Jul; 127(7):814-9. PubMed ID: 10668289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
    Kim DH; Lee DS; Nah HW; Cha JK
    BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.